David S Knopman MD

PubMed

• Contingency of Plasma Dementia Biomarkers on Cognitive Profiles for Prognosis of Incident Dementia: The ARIC Study.
  David S Knopman, James Russell Pike, Michael Griswold, Yifei Lu, Alden Gross
  Neurology. 2026-04-14
• Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging.
  Mingzhao Hu, David S Knopman, Terry Therneau, Angela J Fought, Ekaterina Hofrenning
  Alzheimer's & Dementia. 2026-04-01
• Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neu...
  Michael J Rigby, Hugo Botha, Leland R Barnard, R Ross Reichard, Rachel Larsen
  Movement Disorders. 2026-04-01

Journal Articles

• Association of Initial Β-amyloid Levels with Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment  
  David S Knopman, Bradley F Boeve, Ronald C Petersen, Clifford R Jack, JAMA Neurology
• Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated with MAPT, GRN, and C9orf72 Pathogenic Variants  
  Nupur Ghoshal, Neill R Graff-Radford, David S Knopman, Zbigniew K Wszolek, Joel H Kramer, Bradley F Boeve, Howard J Rosen, JAMA Network Open
• Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia  
  Mary M Machulda, Ronald C Petersen, David S Knopman, Yonas E Geda, Journal of the American Geriatrics Society

Books/Book Chapters

• Goldman's Cecil medicine. 
  Chapter: Regional cerebral dysfunction: higher mental functions. 
  Page 2270 - 2274Knopman DSEditors: Goldman L; Schafer AI.Elsevier/Saunders, Philadelphia, PAEdition 24th,2012
• Goldman's Cecil medicine. 
  Chapter: Alzheimer's disease and other dementias. 
  Page 2274 - 2283Knopman DSEditors: Goldman L; Schafer AI.Elsevier/Saunders, Philadelphia, PAEdition 24th,2012
• Neurodegeneration: the molecular pathology of dementia and movement disorders. 
  Chapter: Clinical aspects of Alzheimer's disease. 
  Page 37 - 50Knopman DEdition 2nd,2011

Abstracts/Posters

• Tdp-43 influences cognition, memory loss and hippocampal atrophy in Alzheimer's disease.
  Josephs K, Whitwell J, Weigand S, Murray M, Tosakulwong N, Liesinger A, Petrucelli L, Knopman D, Boeve B, Ivnik R, Smith G, Jack C, Parisi J, Petersen R, Dickson D, J Neuropathol Exp Neurol, 6/1/2014
• Antemortem characterization of a kindred carrying the non-coding GGGGCC hexanucleotide repeat expansion in C9ORF72.
  Adeli A, Boeve B, DeJesus-Hernandez M, Baker M, Rutherford N, Knopman D, Ivnik R, Fields J, Petersen R, Rademakers R, Neurology, 4/1/2012
• Characterization of the neuropsychiatric features associated with mutations in C9ORF72'MAPT and PGRN.
  Adeli A, Geda Y, Boeve B, Graff-Radford N, DeJesus-Hernandez M, Knopman D, Josephs K, Pedraza O, Rush B, Fields J, Rutherford N, Baker M, Smith G, Ivnik R, Pankratz V,..., Neurology, 4/1/2012

Lectures

• Alzheimers Disease 
  Curitiba, Brazil - 4/1/2004
• Symptoms of Dementia 
  University of Colorado - 3/1/2004
• 7th International Conference on Alzheimer's Disease 
  7/1/2000